SCHEMBL20196381

SCHEMBL20196381

CCCC(=O)C(CCCCN)NC(C)=O

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SIRT6 Q8N6T7 1/20 0.58
▸ SIRT1 Q96EB6 1/20 0.58
▸ TLR2 O60603 2/20 0.50
▸ CHRM2 P08172 1/20 0.50
▸ CHRM4 P08173 1/20 0.50
▸ CHRM1 P11229 1/20 0.50
▸ FOLH1 Q04609 1/20 0.44
▸ SLC6A5 Q9Y345 1/20 0.44
▸ CA1 P00915 2/20 0.42
▸ CA2 P00918 2/20 0.42
▸ ITGB3 P05106 4/20 0.40
▸ ITGA2B P08514 4/20 0.40
▸ DPP8 Q6V1X1 1/20 0.39
▸ DPP9 Q86TI2 1/20 0.39
▸ DPP7 Q9UHL4 1/20 0.39
▸ GNAI3 P08754 1/20 0.39
▸ GNAO1 P09471 1/20 0.39
▸ GNAI1 P63096 1/20 0.39
▸ PAOX Q6QHF9 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13998248 0.86 SIRT6 (0.57) SIRT6SIRT1TLR2CHRM2CHRM4
SCHEMBL21566740 0.86 SIRT6 (0.57) SIRT6SIRT1TLR2CHRM2CHRM4
SCHEMBL14363444 0.81 SIRT6 (0.56) SIRT6SIRT1TLR2CHRM2CHRM4
SCHEMBL19630974 0.81 SIRT6 (0.52) SIRT6SIRT1TLR2CHRM2CHRM4
SCHEMBL19341602 0.81 FOLH1 (0.45) SIRT6SIRT1TLR2FOLH1SLC6A5
SCHEMBL10050111 0.81 SIRT6 (0.52) SIRT6SIRT1TLR2CHRM2CHRM4
SCHEMBL12749404 0.80 SIRT6 (0.58) SIRT6SIRT1TLR2CHRM2CHRM4
SCHEMBL20435077 0.80 SIRT6 (0.58) SIRT6SIRT1TLR2CHRM2CHRM4
SCHEMBL20435058 0.80 SIRT6 (0.58) SIRT6SIRT1TLR2CHRM2CHRM4
SCHEMBL919220 0.79 FOLH1 (0.62) SIRT6SIRT1TLR2FOLH1SLC6A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3327027-A1 CYTOTOXIC PEPTIDES AND ANTIBODY DRUG CONJUGATES THEREOF Pfizer Inc (US) 2018-05-30 — — EP disclosed
Send feedback